Kontrolowanie procesu zapalnego w małych oskrzelach w chorobach obturacyjnych

• Authors: Płusa Tadeusz
• Languages of publication: PL

Keywords

PL

glikokortykosteroid drobnocząsteczkowy; astma; POChP

• Publisher: Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
• Journal: Family Medicine & Primary Care Review
• Year: 2013
• Issue: 2
• Pages: 242-246

Contributors

author

Płusa Tadeusz

References

• Bates JH, Suki B. Assessment of peripheral lung mechanics. Respir Physiol Neurobiol 2008; 163: 54–63.
• Bjermer L. Targeting small airways, a step further in asthma management. Clin Respir J 2011; 5(3): 131–135. doi: 10.1111/j.1752--699X.2011.00240.x.
• Burgel PR. The role of small airways in obstructive airway diseases. Eur Respir Rev 2011; 20(119): 23–33.
• Burgel PR, de Blic J, Chanez P, et al. Update on the roles of distal airways in asthma. Eur Respir Rev 2009; 18: 80–95.
• Carroll N, Cooke C, James A. The distribution of eosinophils and lymphocytes in the lurge and small airways of asthmatics. Eur Respir J 1997; 10: 292–300.
• Chrysofakis G, Tzanakis N, Kyriakoy D, et al. Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. Chest 2004; 125: 71–76.
• Cohen J, Douma WR, ten Hacken NH, et al. Ciclesonide improves measures of small airway involvement in asthma. Eur Respir J 2008; 31(6): 1213–1220.
• De Backer W, Devolder A, Poli G, et al. Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients. J Aerosol Med Pulm Drug Deliv 2010; 23(3): 137–148.
• De Medeiros Matsushita M, da Silva LF, dos Santos MA, et al. Airway proteoglycans are differentially altered in fatal asthma.J Pathol 2005; 207: 102–110.
• Dolhnikoff M, da Silva LF, de Araujo BB, et al. The outer wall of small airways is a major site of remodeling in fatal asthma.J Allergy Clin Immunol 2009; 123: 1090–1097.
• Fabbri LM, Nicolini G, Olivieri D, et al. Inhaled beclometasone dipropionate/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectives. Expert Opin Pharmacother 2008; 9(3): 479–490.
• Fal AM, Niżankowska-Mogilnicka E, Śliwiński P, i wsp. Drobne drogi oddechowe w chorobach obturacyjnych płuc. Pneumonol Alergol Pol 2012; 80(2): 146–151.
• Gentile DA , Skoner DP. New asthma drugs: small molecule inhaled corticosteroids. Curr Opin Pharmacol 2010; 10(3): 260–265.
• Hamid Q, Song Y, Kotsimbos TC, et al. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997; 100: 44–51.
• Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645–2653.
• Hyde DM, Hamid Q, Irvin CG. Anatomy, pathology, and physiology of the tracheobronchial tree: emphasis on the distal airways.J Allergy Clin Immunol 2009; 124: S72–S77.
• Veen JC, Beekman AJ, Bel EH, et al. Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. Am J Respir Crit Care Med 2008; 161: 1902–1906.
• Kraft M, Martin RJ, Wilson S, et al. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am J Respir Crit Care Med 1999; 159: 228–234.
• Kuyper LM, Pare PD, Hogg JC, et al. Characterization of airway plugging in fatal asthma. Am J Med 2003; 115: 6–11.
• Lanes SF, Jara M. The INSPIRE study: influence of prior use and discontinuation of inhaled corticosteroids. Am J Respir Crit Care Med 2008; 178(5): 543–544.
• Leach C, Colice GL, Luskin A. Particle size of inhaled corticosteroids: does it matter? J Allergy Clin Immunol 2009; 124 (Suppl.6):S88–S93.
• Mauad T, Silva LF, Santos MA, et al. Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma. Am J Respir Crit Care Med 2004; 170: 857–862
• Moffatt MF, Kabesch M, Liang L, et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma.Nature 2007; 448: 470–473.
• Moore WC, Bleecker ER, Curran-Everett D, et al. Characterization of the severe asthma phenotype by the National Heart, Lung,and Blood Institute’s Severe Asthma Research Program. J Allergy Clin Immunol 2007; 119: 405–413.
• O’Donnell DE , Laveneziana P, Ora J, et al. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD. Thorax 2009; 64: 216–223.
• Papi A, Paggiaro PL, Nicolini G, et al. Inhaled Combination Asthma Treatment versus SYmbicort (ICAT SY) Study Group. Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. Eur Respir J 2007; 62(4): 682–689.
• Papi A, Paggiaro P, Nicolini G, et al. ICAT SE study group. Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma. Allergy 2007; 62(10): 1182–1188.
• Partridge MR, van der Molen T, Myrseth SE , et al. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006; 6: 13.
• Ranga V, Kleinerman J. Structure and function of small airways in health and disease. Arch Pathol Lab Med 1978; 102: 609–617.
• Saetta M, Mariani M, Panina-Bordignon P, et al. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 165: 1404–1409.
• Scichilone N, Battaglia S, Sorino C, et al. Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma. Allergy 2010; 65(7): 897–902.
• Shiang C, Mauad T, Senhorini A, et al. Pulmonary periarterial inflammation in fatal asthma. Clin Exp Allergy 2009; 39: 1499––1507.
• The ENFUMOSA corss-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network of Understanding Mechanisms of Severe Asthma. Eur Respir J 2003; 22: 470–477.
• Winkler J, Hochhaus G, Derendorf H. How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids.Proc Am Thorac Soc 2004; 1: 356–363.
• van den Berge M, Ten Hacken NH, van der Wiel E, et al. Treatment of the bronchial tree from beginning to end targeting small airway inflammation in asthma. Allergy 2013; 68(1): 16–26.
• Yanai M, Sekizawa K, Ohrui T, et al. Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol 1992; 72: 1016–1023.